Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review

Detalhes bibliográficos
Autor(a) principal: Neres, Joelma Santana dos Santos
Data de Publicação: 2023
Outros Autores: Yahouédéhou, Sètondji Cocou Modeste Alexandre, Goncalves, Marilda Souza
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/61170
Resumo: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Programa Fiocruz de Fomento à Inovação (INOVA).
id CRUZ_8da580319bf7099e698ca9a818c16512
oai_identifier_str oai:www.arca.fiocruz.br:icict/61170
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Neres, Joelma Santana dos SantosYahouédéhou, Sètondji Cocou Modeste AlexandreGoncalves, Marilda Souza2023-11-09T18:36:04Z2023-11-09T18:36:04Z2023NERES, Joelma Santana dos Santos et al. Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review. Pharmaceuticals, v. 16, n. 6, p. 1-11, 2023.1424-8247https://www.arca.fiocruz.br/handle/icict/6117010.3390/ph16060857Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Programa Fiocruz de Fomento à Inovação (INOVA).Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Investigação em Genética e Hematologia Translacional. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Investigação em Genética e Hematologia Translacional. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Farmácia. Laboratório de Pesquisas em Anemia. Salvador, BA, Brasil.Fundação Oswaldo Cruz. Instituto Gonçalo Moniz. Laboratório de Investigação em Genética e Hematologia Translacional. Salvador, BA, Brasil / Universidade Federal da Bahia. Faculdade de Farmácia. Laboratório de Pesquisas em Anemia. Salvador, BA, Brasil.Inconsistent therapeutic responses have been observed among patients with sickle cell anemia (SCA) undergoing hydroxyurea (HU) following the adoption of the standardized protocol. Moreover, this treatment regimen necessitates a prolonged period to reach the maximum tolerated dose in which beneficial therapeutic effects are observed in most SCA patients. To overcome this limitation, several studies have performed HU dose adjustments in SCA patients based on individualized pharmacokinetic profiles. The present systematic mini-review aims to select and analyze published data to present an overview of HU pharmacokinetics studies performed in SCA patients, as well as evaluate the effectiveness of the dose adjustment strategy. A systematic search was performed in the Embase, Pubmed, Scopus, Web of Science, Scielo, Google Scholar, and the Virtual Library of Health databases from December 2020 to August 2022, with a total of five studies included. Inclusion criteria consisted of studies in which the dose adjustment was performed in SCA patients based on pharmacokinetic parameters. Quality analyzes were performed using QAT, while data synthesis was performed according to the Cochrane Manual of Systematic Reviews of Interventions. Analysis of the selected studies revealed improved HU treatment effectiveness using personalized dosages in SCA patients. Moreover, several laboratory parameters were utilized as biomarkers of the HU response, and methods designed to simplify the adoption of this practice were presented. Despite the scarcity of studies on this topic, HU-personalized treatment based on individualized pharmacokinetic profiles represents a viable alternative for SCA patients who are candidates for HU therapy, especially for pediatric patients. Registration number: PROSPERO CRD42022344512.engMDPIAnemia falciformeHidroxiureiaDose personalizadaPerfil farmacocinéticoSickle cell anemiaHydroxyureaPersonalized dosePharmacokinetics profileAnemia falciformeEffectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-reviewinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/61170/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALNeres, Joelma S. S. - Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia.pdfNeres, Joelma S. S. - Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia.pdfapplication/pdf988715https://www.arca.fiocruz.br/bitstream/icict/61170/2/Neres%2c%20Joelma%20S.%20S.%20-%20Effectiveness%20of%20Pharmacokinetic-Guided%20Hydroxyurea%20Dose%20Individualization%20in%20Patients%20with%20Sickle%20Cell%20Anemia.pdfe0487000a08a5130979ce0d1392a89b0MD52icict/611702023-11-09 15:36:05.421oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-11-09T18:36:05Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.en_US.fl_str_mv Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
title Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
spellingShingle Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
Neres, Joelma Santana dos Santos
Anemia falciforme
Hidroxiureia
Dose personalizada
Perfil farmacocinético
Sickle cell anemia
Hydroxyurea
Personalized dose
Pharmacokinetics profile
Anemia falciforme
title_short Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
title_full Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
title_fullStr Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
title_full_unstemmed Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
title_sort Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review
author Neres, Joelma Santana dos Santos
author_facet Neres, Joelma Santana dos Santos
Yahouédéhou, Sètondji Cocou Modeste Alexandre
Goncalves, Marilda Souza
author_role author
author2 Yahouédéhou, Sètondji Cocou Modeste Alexandre
Goncalves, Marilda Souza
author2_role author
author
dc.contributor.author.fl_str_mv Neres, Joelma Santana dos Santos
Yahouédéhou, Sètondji Cocou Modeste Alexandre
Goncalves, Marilda Souza
dc.subject.other.en_US.fl_str_mv Anemia falciforme
Hidroxiureia
Dose personalizada
Perfil farmacocinético
topic Anemia falciforme
Hidroxiureia
Dose personalizada
Perfil farmacocinético
Sickle cell anemia
Hydroxyurea
Personalized dose
Pharmacokinetics profile
Anemia falciforme
dc.subject.en.en_US.fl_str_mv Sickle cell anemia
Hydroxyurea
Personalized dose
Pharmacokinetics profile
dc.subject.decs.en_US.fl_str_mv Anemia falciforme
description Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). Programa Fiocruz de Fomento à Inovação (INOVA).
publishDate 2023
dc.date.accessioned.fl_str_mv 2023-11-09T18:36:04Z
dc.date.available.fl_str_mv 2023-11-09T18:36:04Z
dc.date.issued.fl_str_mv 2023
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv NERES, Joelma Santana dos Santos et al. Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review. Pharmaceuticals, v. 16, n. 6, p. 1-11, 2023.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/61170
dc.identifier.issn.en_US.fl_str_mv 1424-8247
dc.identifier.doi.none.fl_str_mv 10.3390/ph16060857
identifier_str_mv NERES, Joelma Santana dos Santos et al. Effectiveness of pharmacokinetic-guided hydroxyurea dose individualization in patients with sickle cell anemia: a mini-review. Pharmaceuticals, v. 16, n. 6, p. 1-11, 2023.
1424-8247
10.3390/ph16060857
url https://www.arca.fiocruz.br/handle/icict/61170
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/61170/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/61170/2/Neres%2c%20Joelma%20S.%20S.%20-%20Effectiveness%20of%20Pharmacokinetic-Guided%20Hydroxyurea%20Dose%20Individualization%20in%20Patients%20with%20Sickle%20Cell%20Anemia.pdf
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
e0487000a08a5130979ce0d1392a89b0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813009075511754752

Registros relacionados